Dr Thomas Weimbs, USA: Poly cyst Kidney Disease & Ketogenic Diet

Guest Speaker Dr Thomas Weimbs at MHC - II

After a brief introduction session about Dr Thomas Host Shashikant raised a query on how fatal PKD can be (Poly cyst kidney disease) and what is PKD. Dr Thomas to explain to the audience. As asked by the Host, Dr Thomas explained PKD as a genetic disease, and is a chronic kidney disease. It is also a very common disease and as per some statistic 14% of US adult population suffer with this chronic disease and a small percentage are due to genetic causes. Kidney disease can be progressive resulting to renal failures and also leading to Dialysis or Kidney Transplant. Dr Thomas further went on to talk various treatment, cures and various management of patients suffering from PKD, as asked by the Host. Currently the drug-based treatment is limited to just one approved drug, and as per various clinical trial for this drug the result show that it slows the progression of PKD and not permanent cure or reversal. Dr Thomas did say that its not clear about how much a patient of PKD can benefit from this drug, but various side effect are prevalent and expensive. While discussing he also discussed about early detention of PKD that can be sourced as genetics and also diagnosed by ultrasound. Various symptoms and causes of PKD was discussed, mainly hypertension as one of the symptoms and causes of PKD that can be detected by carrying on an Ultrasound. Various other detail for PKD was discussed into the diets, especially ketogenic diets can be beneficial among the patients of PKD, preview the video for all details

Click on the link below, to preview Video Session of 46 minutes with host Shashikant

▶️Preview Video session

About Dr Thomas Weimbs

Dr Thoman is a Professors at University of California, located in Santa Barbara, USA. He completed his PhD from University of Cologne, Germany and went on conducting post-doctoral research at university of California, San Francisco, USA in 1999.
He runs Weimbs Laboratory at UC Santa Barbara. The Lab aims to focus on laboratory is the investigation of molecular mechanisms underlying polycystic kidney disease (PKD) and related renal diseases, and the development of new therapies. Research in the Weimbs Laboratory has already led to better understanding of aberrantly regulated signaling mechanisms in PKD and proposed possible new strategies for disease treatment. The laboratory strives to discover new basic mechanisms of epithelial cell function and kidney physiology, and to translate these findings into the clinic. The training of future scientists at the postdoctoral, graduate and undergraduate level is another important mission of the Weimbs Laboratory.